Back

Evaluating the impact of a community-engagement intervention on the uptake of childhood vaccines in England: A synthetic control analysis

Amin, M. S.; Zhang, X.; Green, M. A.; Holford, D.; Hemingway, C.; Ismail, A.; Essale, N.; Doyle, V.; Taegtmeyer, M.; Hungerford, D.

2026-05-04 pediatrics
10.64898/2026.05.01.26352232 medRxiv
Show abstract

ObjectiveTo evaluate the impact of equity-focused community-engagement initiatives on the uptake of five routine childhood vaccinations. DesignQuasi-experimental study within a synthetic control analysis framework. SettingPrimary care in England between April 2019 and March 2025. Childhood vaccination data were obtained from the Cover of Vaccination Evaluated Rapidly (COVER) programme. InterventionThe Health Equity Liverpool Project (HELP) is a community-engagement vaccination initiative implemented between October 2023 and June 2024 across nine sites in central and north Liverpool. Activities were co-developed with local partners and delivered in neighbourhoods with persistently low childhood vaccine coverage. Intervention practices were defined as those located within 1 km of HELP delivery sites (n=19). A weighted combination of non-intervention practices across England (n=5826) was used to construct a synthetic control group. Main outcomesQuarterly counts of vaccinated children following intervention implementation for first doses of the measles, mumps and rubella vaccine (MMR1 at 24 months and at 5 years), second dose of MMR (MMR2 at 5 years), pneumococcal conjugate vaccine (PCV at 24 months), the 6-in-1 vaccine, covering diphtheria, tetanus, pertussis, polio, haemophilus influenzae type b, and hepatitis B (at 12 months), and the rotavirus vaccine (at 12 months). ResultsFollowing HELP, rotavirus vaccine uptake increased by 10.03% (95% CI 0.37% to 24.63%), corresponding to 120 (95% CI 4 to 295) additional infants vaccinated in the intervention group compared to the synthetic control. Similarly, 6-in-1 vaccine uptake rose by 11.56% (95% CI 2.37% to 25.56% [~]143 95% CI 29 to 317 additional children vaccinated. No statistically significant changes were observed for MMR1, MMR2, or PCV. Improvements were short-lived, with uptakes returning to pre-intervention levels after approximately nine months. ConclusionsCommunity-engagement vaccination interventions may produce a modest short-term improvement in uptake of selected early life vaccines but show limited evidence of benefit for MMR uptake. Our findings suggest that such approaches are unlikely to have a sustained impact without long-term investment, integration into existing immunisation systems and addressing the wider social determinants of health. What is already known on this topic?O_LIChildhood vaccination rates in England have declined over the last decade and inequalities in uptake are persistent andwidening. C_LIO_LIChildren in socioeconomically deprived areas are less likely to receive routine vaccinations, reflecting both structural barriers and vaccine hesitancy driven by misinformation and lack of trust. C_LIO_LIInnovative community engagement interventions are recommended to address these inequalities, yet evidence of their effectiveness remains limited. C_LI What this study adds?O_LIOur study shows that hyperlocal community engagement interventions can increase uptake of early-life infant vaccines (rotavirus and 6-in-1) by around 10-12% but provides limited evidence of similar improvements for the MMR vaccine. C_LIO_LIThe observed improvements in infant vaccines were transient, returning to baseline levels after approximately nine months, suggesting that one-off initiatives may not produce sustained public health gains without tackling wider social determinants of health. C_LI

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Archives of Disease in Childhood
15 papers in training set
Top 0.1%
21.9%
2
The Lancet Global Health
24 papers in training set
Top 0.1%
12.0%
3
BMJ Open
554 papers in training set
Top 2%
9.8%
4
BMC Medicine
163 papers in training set
Top 0.6%
6.2%
5
PLOS Medicine
98 papers in training set
Top 0.6%
6.1%
50% of probability mass above
6
Nature Communications
4913 papers in training set
Top 38%
3.9%
7
Vaccine
189 papers in training set
Top 0.8%
3.5%
8
BMJ Global Health
98 papers in training set
Top 1%
3.0%
9
JAMA Network Open
127 papers in training set
Top 1%
2.4%
10
PLOS ONE
4510 papers in training set
Top 51%
1.8%
11
Public Health Nutrition
14 papers in training set
Top 0.3%
1.8%
12
BMC Public Health
147 papers in training set
Top 3%
1.8%
13
Nature Medicine
117 papers in training set
Top 2%
1.8%
14
BMJ Paediatrics Open
21 papers in training set
Top 0.4%
1.7%
15
Eurosurveillance
80 papers in training set
Top 0.6%
1.7%
16
Social Science & Medicine
15 papers in training set
Top 0.4%
1.7%
17
The Lancet Regional Health - Europe
32 papers in training set
Top 0.1%
1.6%
18
eClinicalMedicine
55 papers in training set
Top 0.8%
1.4%
19
BMJ
49 papers in training set
Top 0.7%
1.4%
20
Canadian Medical Association Journal
15 papers in training set
Top 0.2%
1.3%
21
The Lancet Infectious Diseases
71 papers in training set
Top 2%
1.3%
22
The Journal of Pediatrics
15 papers in training set
Top 0.5%
1.2%
23
The Journal of Infectious Diseases
182 papers in training set
Top 4%
0.9%
24
Brain, Behavior, and Immunity
105 papers in training set
Top 3%
0.8%
25
The Lancet
16 papers in training set
Top 0.8%
0.7%
26
International Journal of Epidemiology
74 papers in training set
Top 3%
0.7%
27
Journal of Clinical Epidemiology
28 papers in training set
Top 0.6%
0.7%
28
Preventive Medicine Reports
14 papers in training set
Top 0.5%
0.7%
29
JMIR Public Health and Surveillance
45 papers in training set
Top 4%
0.6%